A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/ hyperactivity disorder
Joseph Biederman, Eric Mick, Craig Surman, Robert Doyle, Paul Hammerness, Meghan Kotarski, Thomas Spencer
Research output: Contribution to journal › Article › peer-review
68Scopus
citations
Fingerprint
Dive into the research topics of 'A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/ hyperactivity disorder'. Together they form a unique fingerprint.